Form 13-F position report

ELEVANCE HEALTH INC.

Reported by STATE OF WISCONSIN INVESTMENT BOARD

ELV CUSIP 036752103 Manager CIK 0000854157

Reported 458,900 shares, up 2,816 (0.6%) from the prior quarter.

Reported value 9.0%; share count 0.6% vs. the prior quarter.

Added
% of reported 13F value 0.61% This manager · Q4 2023
Shares 458,900 Quarter-end amount reported
Reported value $216,398,884 Fair value at quarter end
Consecutive quarters held 37 Through Q4 2023

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 275908000
2021-12-31 308360000
2022-03-31 210689000
2022-06-30 191801000
2022-09-30 164013000
2022-12-31 185092913
2023-03-31 191569721
2023-06-30 213841220
2023-09-30 198588095
2023-12-31 216398884
2024-03-31 238790263
2024-06-30 174918910
2024-09-30 92118520
2024-12-31 50453715
2025-03-31 57751814
2025-06-30 48603275
2025-09-30 44872644
2025-12-31 43119403
2026-03-31 34832566
2026-06-30 45393594

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for ELEVANCE HEALTH INC. held by STATE OF WISCONSIN INVESTMENT BOARD.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2026 Reduced 117,378 -1,606 (-1.3%) 0.09% $45,393,594 2026-08-14
Q1 2026 Reduced 118,984 -4,021 (-3.3%) 0.08% $34,832,566 2026-05-15
Q4 2025 Reduced 123,005 -15,868 (-11.4%) 0.1% $43,119,403 2026-02-17
Q3 2025 Added 138,873 +13,916 (11.1%) 0.1% $44,872,644 2025-11-14
Q2 2025 Reduced 124,957 -7,818 (-5.9%) 0.12% $48,603,275 2025-08-14
Q1 2025 Reduced 132,775 -3,993 (-2.9%) 0.15% $57,751,814 2025-05-15
Q4 2024 Reduced 136,768 -40,383 (-22.8%) 0.13% $50,453,715 2025-02-14
Q3 2024 Reduced 177,151 -145,661 (-45.1%) 0.23% $92,118,520 2024-11-14
Q2 2024 Reduced 322,812 -137,693 (-29.9%) 0.46% $174,918,910 2024-08-14
Q1 2024 Added 460,505 +1,605 (0.3%) 0.63% $238,790,263 2024-05-14
Q4 2023 Added 458,900 +2,816 (0.6%) 0.61% $216,398,884 2024-02-12
Q3 2023 Reduced 456,084 -25,226 (-5.2%) 0.62% $198,588,095 2023-11-14
Q2 2023 Added 481,310 +64,682 (15.5%) 0.6% $213,841,220 2023-08-14
Q1 2023 Added 416,628 +55,802 (15.5%) 0.57% $191,569,721 2023-05-15
Q4 2022 Reduced 360,826 -246 (-0.1%) 0.6% $185,092,913 2023-02-14
Q3 2022 Reduced 361,072 -36,378 (-9.2%) 0.52% $164,013,000 2022-11-14
Q2 2022 Reduced 397,450 -31,459 (-7.3%) 0.5% $191,801,000 2022-08-15
Q1 2022 Reduced 428,909 -236,320 (-35.5%) 0.44% $210,689,000 2022-05-13
Q4 2021 Reduced 665,229 -74,868 (-10.1%) 0.6% $308,360,000 2022-02-11
Q3 2021 Added 740,097 +80,370 (12.2%) 0.57% $275,908,000 2021-11-12
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

1750 managers reported ELEVANCE HEALTH INC. for Q4 2023.

Managers reporting ELEVANCE HEALTH INC. in Q4 2023.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Added 21,227,190 +23,807 0.22% $10,009,893,715 37 qtrs
BlackRock Inc Added 21,030,599 +536,585 0.25% $9,917,189,469 37 qtrs
PRICE T ROWE ASSOCIATES INC MD Reduced 11,923,593 -107,780 0.76% $5,622,691,000 37 qtrs
STATE STREET CORPORATION Reduced 10,409,617 -38,378 0.24% $4,908,758,993 33 qtrs
WELLINGTON MANAGEMENT GROUP LLP Reduced 5,910,392 -682,374 0.52% $2,787,104,451 37 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 4,517,729 +97,290 0.22% $2,124,696,052 37 qtrs
Sanders Capital LLC Added 4,457,986 +196,010 3.89% $2,102,207,878 37 qtrs
FMR LLC Reduced 3,965,986 -249,992 0.14% $1,870,200,599 37 qtrs
AMERIPRISE FINANCIAL INC Added 3,711,807 +416,803 0.52% $1,750,409,902 37 qtrs
Capital International Investors Added 3,374,709 +248,150 0.36% $1,591,237,336 20 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2023
Filed
February 12, 2024
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
458,900
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.